Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies and products, has filed a Patent Cooperation Treaty (“PCT”) that seeks international protection of its proprietary cannabinoid infusion system for beverages, foods and consumer products. The PCT is aimed at seeking patent protections for inventions resulting from CBGL’s Project Varin research program. Specifically, the application relates to innovative methods for the creation of highly bioavailable and ultra-fast-acting cannabinoids for use in beverages, food, topicals and other applications. Noting that this technology is revolutionary, the company believes its breakthrough research could potentially result in substantial cost reductions and efficacy enhancements, as well as significantly faster onset of active cannabinoids ingredients. “At Cannabis Global we hold the opinion that not only will cannabis be soon descheduled and legalized within the United States, but in many other areas of the world,” said Cannabis Global CEO Arman Tabatabaei. “It is important for our company to start on the PCT process as soon as is possible to ensure we will be able to capitalize on the expected wave of global cannabis legalization, especially relating to Southeast Asia and within the European Union where legalization and decriminalization is already well underway.”
To view the full press release, visit https://ibn.fm/fn0Ti
About Cannabis Global Inc.
Cannabis Global, formerly known as MCTC Holdings Inc., is a fully audited and reporting company with the U.S. Securities & Exchange Commission. The company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp- and cannabis-infusion technologies. The company does not engage in the production, distribution or sales of any controlled substances, including marijuana. CBGL has an actively growing portfolio of intellectual property, having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, designed to develop new delivery methods for rare cannabinoid tetrahydrocannabivarin (“THV-C”) and to develop products based on this cannabinoid. For more information about the company, visit www.CannabisGlobalInc.com.
NOTE TO INVESTORS: The latest news and updates relating to CBGL are available in the company’s newsroom at http://ibn.fm/CBGL
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.qualitystocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php